Empaglifozin cardiovascular benefit: can we separate fact from fiction?

Authors

  • Robson Brandão Silva Brazilian Society of Cardiology

DOI:

https://doi.org/10.17267/2675-021Xevidence.v1i1.2095

Downloads

Download data is not yet available.

Published

06/04/2019

Issue

Section

Critical Appraisal of Evidence

How to Cite

1.
Silva RB. Empaglifozin cardiovascular benefit: can we separate fact from fiction?. Evidence [Internet]. 2019 Jun. 4 [cited 2024 Nov. 22];1(1):43-5. Available from: https://www5.bahiana.edu.br/index.php/evidence/article/view/2095